InsiderClue
Insiders · Profile

Liau Gene

EVP Research & Preclinical Dev at Stoke Therapeutics. Filing since 22 May 2020. CIK 0001780082

Company
Date
Role
Action
Shares
Amount
Of holding
STOK Stoke Therapeutics, Inc.
2 Mar 2021
EVP Research & Preclinical Dev
Sold, plan not stated
5,195
$327.55K
19.6%
STOK Stoke Therapeutics, Inc.
28 Dec 2020
EVP Research & Preclinical Dev
Sold, plan not stated
149
$8.75K
0.7%
STOK Stoke Therapeutics, Inc.
19 Oct 2020
EVP Research & Preclinical Dev
Sold, plan not stated
32,000
$1.21M
70.3%
STOK Stoke Therapeutics, Inc.
16 Oct 2020
EVP Research & Preclinical Dev
Sold, plan not stated
5,851
$234.04K
30.2%
STOK Stoke Therapeutics, Inc.
13 Oct 2020
EVP Research & Preclinical Dev
Sold, plan not stated
1,649
$65.96K
10.9%
STOK Stoke Therapeutics, Inc.
1 Jun 2020
EVP Research & Preclinical Dev
Sold, plan not stated
20,000
$527.04K
59.7%
STOK Stoke Therapeutics, Inc.
22 May 2020
EVP Research & Preclinical Dev
Sold, plan not stated
7,500
$225.00K
35.7%
7 decisions on file.